Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and Matrigel invasion

Journal of Cell Science

Volumn 113, Issue 1, 2000, Pages 123-134

  Webb, Donna J ^a   Nguyen, Diem H D ^a   Gonias, Steven L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Low density lipoprotein receptor related protein; MAP kinase; Urokinase; VLDL receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIBODY; APROTININ; COMPLEMENTARY RNA; ENZYME INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0033959101     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.113.1.123     Document Type: Article

References (61)

1. Anderson, R. G., Vasile, E., Mello, R. J., Brown, M. S. and Goldstein, J. L. (1978). Immunocytochemical visualization of coated pits and vesicles in human fibroblasts: relation to low density lipoprotein receptor distribution. Cell 15, 919-933.
2. Andreasen, P. A., Kjoller, L., Christensen, L. and Duffy, M. J. (1997). The urokinase-type plasminogen activator system in cancer metastasis: A review. Int. J. Cancer 72, 1-22.
3. 5 to promote tumor cell dissemination in vivo. J. Clin. Invest. 99, 1390-1398.
4. Busso, N., Masur, S. K., Lazega, D., Waxman, S. and Ossowski, L. (1994). Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126, 259-270.
5. Cajot, J. F., Scheuning, W. D., Medcalf, R. L., Bamat, J., Testuz, J., Liebermann, L. and Sordat, B. (1989). Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J. Cell Biol. 109, 915-925.
6. Chapman, H. A. (1997). Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 133, 714-724.
7. Chu, Y., Solski, P. A., Khosravi-Far, R., Der, C. J. and Kelly, K. (1996). The mitogen-activated protein kinase phosphatases PACI, MKP-1, and MKP-2 have unique sub strate specificities and reduced activity in vivo toward ERK2 sevenmaker mutation. J. Biol. Chem. 271, 6497-6501.
8. 2-Macroglobulin recep tor/LDL receptor-related (LRP)-dependent internalization of the urokinase receptor. J. Cell Biol. 131, 1609-1622.
9. 5 is localized at focal contacts by HT 1080 fibrosarcoma calls and human fibroblasts attached to vitronectin. Cell Adhes. Commun. 1, 279-293.
10. Cubellis, M. V., Nolli, M. L., Cassani, G. and Blasi, F. (1986). Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. J. Biol. Chem. 261, 15819-15822.
11. Degryse, B., Resnati, M., Rabbani, S. A., Villa, A., Fazioli, F. and Blasi, F. (1999). Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 94, 649-662
12. Deutsch, D. G. and Mertz, E. T. (1970). Plasminogen: purification from human plasma by affinity chromatography. Science 170, 1095-1096.
13. Dumler, I., Kopmann, A., Weis, A., Mayboroda, O. A., Wagner, K., Gulba, D. C., Haller, H. (1999). Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19, 290-297.
14. 3 function through integrin-associated protein. J. Cell Biol. 135, 533-544.
15. Glass, W. F. II, Teng, P. R. and Haney, L. B. (1996). Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum. J. Am. Soc. Nephrol. 7, 2230-2243.
16. Gliemann, J. (1998). Receptors of the low density lipoprotein receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol. Chem. 379, 951-964.
17. Godyna, S., Liau, G., Popa, I., Stefansson, S. and Argraves, S. (1995). Identification of low density lipoprotein receptor-related protein as an endocytic receptor for thrombospondin-1. J. Cell Biol. 129, 1403-1410.
18. Goldstein, J. L., Anderson, R. G. W. and Brown, M. S. (1979). Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279, 679-684.
19. 2-macroglobulin recep tor/LRP: A growth regulatory axis. Ann. NY Acad. Sci. 737, 273-290.
20. Gyetko, M. R., Chen, G.-H., McDonald, R. A., Goodman, R., Huffnagle, G. B., Wilkinson, C. C., Fuller, J. A. and Toews, G. B. (1996). Urokinase is required for the pulmonary inflammatory response to cryptococcus neoformans. J. Clin. Invest. 97, 1818-1826.
21. Hughes, P. E., Renshaw, M. W., Pfaff, M., Forsyth, J., Keivens, V. M., Schwartz, M. A. and Ginsberg, M. H. (1997). Suppression of integrin activation: a novel function of ras/raf-initiated MAP kinase pathway. Cell 88, 521-530.
22. Hussaini, I. M., Brown, M. D., Weaver, A. M., Carpenter, J., Karns, L. R., VandenBerg, S. R. and Gonias, S. L. (1999). Stable antisense RNA expression neutralizes the activity of low density lipoprotein receptor-related protein and promotes urokinase acculumation in the medium of an astrocytic tumor cell line. Antisense Nucl. Acid Drug Dev. 9, 183-190
23. 2-macroglobulin. J. Biol. Chem. 256, 8134-8139.
24. Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S. and Vande Woude, G. F. (1998). The mutationally activated Met receptor mediates motility and metas tasis. Proc. Nat. Acad. Sci. USA 95, 14417-14422.
25. 5-directed cell motility but not adhesion on vitronectin. J. Cell Biol. 127, 859-866.
26. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., de Lanerolle, P. and Cheresh, D. A. (1997). Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137, 481-492.
27. Konakova, M., Hucho, F. and Schleuning, W.-D. (1998). Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur. J. Biochem. 253, 421-429.
28. Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C. and Binder, B. R. (1997). Uro kinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272, 28563-28567.
29. 2-macroglobulin receptor/low density lipoprotein re ceptor-related protein binds and internalizes pseudumonas exotoxin A. J. Biol. Chem. 267, 12429-12423.
30. 2-macroglobulin receptor mediates cellular up take of pro-urokinase. J. Biol. Chem. 268, 21862-21867.
31. Krieger, M. and Herz, J. (1994). Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63, 601-37.
32. Laug, W. E., Wang, K., Mundi, R., Rideout, W., Kruithof, E. K. O. and Bogenmann, E. (1992). Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT 1080 sarcoma cells. Int. J. Cancer 52, 298-304.
33. Lengyel, E., Wang, H., Gum, R., Simon, C., Wang, Y. and Boyd, D. (1997). Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene 14, 2563-2573.
34. 2 integrins in vivo. J. Exp. Med. 188, 1029-1037.
35. Meissauer, A., Kramer, M. D., Hofmann, M., Erkell, L. J., Jacob, E., Schirrmacher, V. and Brunner, G. (1991). Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp. Cell Res. 192, 453-459.
36. Meissauer, A., Kramer, M. D., Schirrmacher, V. and Brunner, G. (1992). Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro. Exp. Cell Res. 199, 179-190.
37. Mohanam, S., Sawaya, R., McCutcheon, I., Ali-Osman, F., Boyd, D. and Rao, J. S. (1993). Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 53, 4143-4147.
38. Nguyen, D. H. D., Hussaini, I. M. and Gonias, S. L. (1998). Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J. Biol. Chem. 273, 8502-8507.
39. Nguyen, D. H. D., Catling, A. D., Webb, D. J., Sankovic, M., Walker, L. A., Somlyo, A. V., Weber, M. J. and Gonias, S. L. (1999). Myosin light chain kinase functions down stream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J. Cell Biol. (in press).
40. Nykjaer, A., Conese, M., Christensen, E. I., Olson, D., Cremona, O., Gliemann, J. and Blasi, F. (1997). Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J. 16, 2610-2620.
41. Okada, S. S., Grobmyer, S. R. and Barnathan, E. S. (1996). Contrasting effects of plas minogen activators, urokinase receptor and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler. Thromb. Vasc. Biol. 16, 1269-1276.
42. Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F. and Fazioli, F. (1996). Proteolytic cleavage of the urokinase receptor substitutes for the antagonist-induced chemotactic effect. EMBO J. 15, 1572-1582.
43. Saksela, O. and Rifkin, D. B. (1988). Cell-associated plasminogen activation. Regulation and physiological functions. Annu. Rev. Cell Biol. 4, 93-126.
44. Shapiro, R. L., Duquette, J. G., Nunes, I., Roses, D. F., Harris, M. N., Wilson, E. L. and Rifkin, D. B. (1997). Urokinase-type plasminogen activator-deficient mice are predis posed to staphylococcal botryomycosis, pleuritis and effacement of lymphoid follicles. Am. J. Pathol. 150, 359-369.
45. Simon, C., Juarez, J, Nicolson, G. L. and Boyd, D. (1996) Effect of PD098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression in vitro invasion. Cancer Res. 56, 5369-5374.
46. Stahl, A. and Mueller, B. M. (1994). Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res. 54, 3066-3071.
47. Stockinger, W., Hengstschläger-Ottnad, E., Novak, S., Matus, A., Hüttinger, M., Bauer, J., Lassmann, H., Schneider, W. J. and Nimpf, J. (1998). The low density lipoprotein receptor gene family. J. Biol. Chem. 273, 32213-32221.
48. Stoppelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F. and Assoian, R. K. (1985). Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Nat. Acad. Sci. USA 82, 4939-4943.
49. Strickland, D. K., Kounnas, M. Z. and Argraves, W. S. (1995). LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9, 890-898.
50. Tang, H., Kerins, D. M., Hao, Q., Inagami, T. and Vaughan, D. E. (1998). The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 273, 18268-18272.
51. TrommsdorfT, M., Borg, J.-P., Margolis, B. and Herz, J. (1998). Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560.
52. Trommsdorff, M., Gotthardt, M, Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R., Richardson, J. A. and Herz, J. (1999). Reeler/disabled-like dis ruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE 2. Cell 97, 689-701.
53. Tsuboi, R. and Rifkin, D. B. (1990). Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Int. J. Cancer. 46, 56-60.
54. Vassalli, J.-D., Baccino, D. and Belin, D. (1985). A cellular binding site for the Mr 55, 000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100, 86-92.
55. Weaver, A. M., Hussaini, I. M., Mazar, A., Henkin, J. and Gonias, S. L. (1997). Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J. Biol. Chem. 272, 14372-14379.
56. Webb, C. P., Van Aelst, L., Wigler, M. H. and Vande Woude, G. F. (1998). Signaling pathways in Ras-mediated tumorgenicity and metastasis. Proc. Nat. Acad. Sci. USA 95, 8773-8778.
57. 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity. Eur. J. Biochem. 234, 714-722.
58. Webb, D. J., Nguyen, D. H. D., Sankovic, M. and Gonias, S. L. (1999). The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J. Biol. Chem. 274, 7412-7420.
59. 2-macroglobulin receptor associated protein. Thromb. Haemost. 78, 880-886.
60. Xie, H., Pallero, M. A., Gupta, K., Chang, P., Ware, M. F., Witke, W., Kwiatkowski, D. J., Lauffenburger, D. A., Murphy-Ullrich, J. E. and Wells, A. (1998). EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesion independently of the motility-associated PLCγ signaling pathway. J. Cell Sci. 111, 615-624.
61. Yatohgo, T., Izumi, M., Kashiwagi, H. and Hayashi, M. (1988). Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13, 281-292.